Feasibility and Safety of Anlotinib Plus Docetaxel versus Docetaxel Monotherapy in Patients with Previously Immunotherapy-Treated NSCLC: A Retrospective Exploratory Study

Li DW, Li YD, Jin H

International Journal of General Medicine 2025, 18:2319-2331

Published Date: 28 April 2025